메뉴 건너뛰기




Volumn 15, Issue 2, 2014, Pages 629-635

Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide

Author keywords

Apoptosis; Etoposide; HL 60; Leukemia; Mcl 1; SiRNA

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; MCL1 PROTEIN, HUMAN; MESSENGER RNA; MYELOID LEUKEMIA FACTOR 1; SMALL INTERFERING RNA;

EID: 84894679246     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.629     Document Type: Article
Times cited : (28)

References (34)
  • 1
    • 84872678419 scopus 로고    scopus 로고
    • Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells
    • Akagi H, Higuchi H, Sumimoto H, et al (2013). Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer, 16, 100-10.
    • (2013) Gastric Cancer , vol.16 , pp. 100-110
    • Akagi, H.1    Higuchi, H.2    Sumimoto, H.3
  • 3
    • 75549084068 scopus 로고    scopus 로고
    • MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts
    • Brunelle JK, Ryan J, Yecies D, Opferman JT, Letai A (2009). MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts. J Cell Biol, 187, 429-42.
    • (2009) J Cell Biol , vol.187 , pp. 429-442
    • Brunelle, J.K.1    Ryan, J.2    Yecies, D.3    Opferman, J.T.4    Letai, A.5
  • 4
    • 40749122965 scopus 로고    scopus 로고
    • Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis
    • Chetoui N, Sylia K, Gagnon-Houde JV, et al (2008). Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol Cancer Res, 6, 42-52.
    • (2008) Mol Cancer Res , vol.6 , pp. 42-52
    • Chetoui, N.1    Sylia, K.2    Gagnon-Houde, J.V.3
  • 5
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talaly P (1984). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul, 22, 27-55.
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talaly, P.2
  • 7
    • 84856270102 scopus 로고    scopus 로고
    • Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
    • Glaser SP, Lee EF, Trounson E, et al (2012). Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev, 26, 120-5.
    • (2012) Genes Dev , vol.26 , pp. 120-125
    • Glaser, S.P.1    Lee, E.F.2    Trounson, E.3
  • 8
    • 84878445414 scopus 로고    scopus 로고
    • Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFkappaB activity
    • Han P, Luan Y, Lin Y, et al (2013). Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFkappaB activity. Mol Cell Biochem, 379, 171-80.
    • (2013) Mol Cell Biochem , vol.379 , pp. 171-180
    • Han, P.1    Luan, Y.2    Lin, Y.3
  • 9
    • 77149178712 scopus 로고    scopus 로고
    • The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs
    • High LM, Szymanska B, WilczynskaI-Kalak U, et al (2010). The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs. Mol Pharmacol, 77, 483-94.
    • (2010) Mol Pharmacol , vol.77 , pp. 483-494
    • High, L.M.1    Szymanska, B.2    Wilczynskai-Kalak, U.3
  • 10
    • 34247511009 scopus 로고    scopus 로고
    • Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
    • Hussain SR, Cheney CM, Johnson AJ, et al (2007). Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity. Clin Cancer Res, 13, 2144-50.
    • (2007) Clin Cancer Res , vol.13 , pp. 2144-2150
    • Hussain, S.R.1    Cheney, C.M.2    Johnson, A.J.3
  • 11
    • 84863418151 scopus 로고    scopus 로고
    • Action and reaction: the biological response to siRNA and its delivery vehicles
    • Kanasty RL, Whitehead KA, Vegas AJ, Anderson DG (2012). Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther, 20, 513-24.
    • (2012) Mol Ther , vol.20 , pp. 513-524
    • Kanasty, R.L.1    Whitehead, K.A.2    Vegas, A.J.3    Anderson, D.G.4
  • 12
    • 67349232739 scopus 로고    scopus 로고
    • Effectiveness of small interfering RNA (siRNA) against the Mcl-1 gene in a canine mammary gland tumor cell line
    • Kano R, Yano T, Nagamatsu K, et al (2009). Effectiveness of small interfering RNA (siRNA) against the Mcl-1 gene in a canine mammary gland tumor cell line. Res Vet Sci, 87, 64-6.
    • (2009) Res Vet Sci , vol.87 , pp. 64-66
    • Kano, R.1    Yano, T.2    Nagamatsu, K.3
  • 13
    • 0032006805 scopus 로고    scopus 로고
    • Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse
    • Kaufmann SH, Karp JE, Svingen PA, et al (1998). Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood, 91, 991-1000.
    • (1998) Blood , vol.91 , pp. 991-1000
    • Kaufmann, S.H.1    Karp, J.E.2    Svingen, P.A.3
  • 14
    • 0027480450 scopus 로고
    • MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2
    • Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993). MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A, 90, 3516-20.
    • (1993) Proc Natl Acad Sci U S A , vol.90 , pp. 3516-3520
    • Kozopas, K.M.1    Yang, T.2    Buchan, H.L.3    Zhou, P.4    Craig, R.W.5
  • 16
    • 84887572318 scopus 로고    scopus 로고
    • Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma
    • Li G, Chang H, Zhai YP, Xu W (2013). Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 4943-52.
    • (2013) Asian Pac J Cancer Prev , vol.14 , pp. 4943-4952
    • Li, G.1    Chang, H.2    Zhai, Y.P.3    Xu, W.4
  • 17
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method
    • Livaki KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods, 25, 402-8.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livaki, K.J.1    Schmittgen, T.D.2
  • 18
    • 0030701895 scopus 로고    scopus 로고
    • Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis
    • Martins LM, Mesner PW, Kottke TJ, et al (1997). Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood, 90, 4283-96.
    • (1997) Blood , vol.90 , pp. 4283-4296
    • Martins, L.M.1    Mesner, P.W.2    Kottke, T.J.3
  • 19
    • 34248356003 scopus 로고    scopus 로고
    • Cellular response to etoposide treatment
    • Montecucco A, Biamonti G (2007). Cellular response to etoposide treatment. Cancer Lett, 252, 9-18.
    • (2007) Cancer Lett , vol.252 , pp. 9-18
    • Montecucco, A.1    Biamonti, G.2
  • 20
  • 21
    • 84874045787 scopus 로고    scopus 로고
    • RNA interference as a plausible anticancer therapeutic tool
    • Ramachandran PV, Ignacimuthu S (2012). RNA interference as a plausible anticancer therapeutic tool. Asian Pac J Cancer Prev, 13, 2445-52.
    • (2012) Asian Pac J Cancer Prev , vol.13 , pp. 2445-2452
    • Ramachandran, P.V.1    Ignacimuthu, S.2
  • 22
    • 59849103061 scopus 로고    scopus 로고
    • Drug delivery of siRNA therapeutics: potentials and limits of nanosystems
    • Reischl D, Zimmer A (2009). Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine, 5, 8-20.
    • (2009) Nanomedicine , vol.5 , pp. 8-20
    • Reischl, D.1    Zimmer, A.2
  • 23
    • 74549195798 scopus 로고    scopus 로고
    • Current and emerging therapies for acute myeloid leukemia
    • Robak T, WierzbowskaI A (2009). Current and emerging therapies for acute myeloid leukemia. Clin Ther, 31, 2349-70.
    • (2009) Clin Ther , vol.31 , pp. 2349-2370
    • Robak, T.1    Wierzbowska, I.A.2
  • 24
    • 77954386712 scopus 로고    scopus 로고
    • RNA interference as a gene knockdown technique
    • Shan G (2010). RNA interference as a gene knockdown technique. Int J Biochem Cell Biol, 42, 1243-51.
    • (2010) Int J Biochem Cell Biol , vol.42 , pp. 1243-1251
    • Shan, G.1
  • 25
    • 48849098719 scopus 로고    scopus 로고
    • Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck
    • Skoda C, Erovic BM, Wachek V, et al (2008). Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck. Oncol Rep, 19, 1499-503.
    • (2008) Oncol Rep , vol.19 , pp. 1499-1503
    • Skoda, C.1    Erovic, B.M.2    Wachek, V.3
  • 26
    • 64049106525 scopus 로고    scopus 로고
    • Immunotherapy of acute myeloid leukemia: current approaches
    • Smits EL, Berneman ZN, Van Tendeloo VF (2009). Immunotherapy of acute myeloid leukemia: current approaches. Oncologist, 14, 240-52.
    • (2009) Oncologist , vol.14 , pp. 240-252
    • Smits, E.L.1    Berneman, Z.N.2    Van Tendeloo, V.F.3
  • 27
    • 84879377399 scopus 로고    scopus 로고
    • The prevalent predicament of relapsed acute myeloid leukemia
    • Szer J (2012). The prevalent predicament of relapsed acute myeloid leukemia. Hematol Am Soc Hematol Educ Program, 2012, 43-8.
    • (2012) Hematol Am Soc Hematol Educ Program , vol.2012 , pp. 43-48
    • Szer, J.1
  • 28
    • 3042570258 scopus 로고    scopus 로고
    • Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide
    • Thallinger C, Wolschek MF, Maierhofer H, et al (2004). Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide. Clin Cancer Res, 10, 4185-91.
    • (2004) Clin Cancer Res , vol.10 , pp. 4185-4191
    • Thallinger, C.1    Wolschek, M.F.2    Maierhofer, H.3
  • 29
    • 0038806293 scopus 로고    scopus 로고
    • Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model
    • Thallinger C, Woschek MF, Wacheck V, et al (2003). Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. J Invest Dermatol, 120, 1081-6.
    • (2003) J Invest Dermatol , vol.120 , pp. 1081-1086
    • Thallinger, C.1    Woschek, M.F.2    Wacheck, V.3
  • 30
    • 42049091619 scopus 로고    scopus 로고
    • Unique biology of Mcl-1: therapeutic opportunities in cancer
    • Warr MR, Shore GC (2008). Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med, 8, 138-47.
    • (2008) Curr Mol Med , vol.8 , pp. 138-147
    • Warr, M.R.1    Shore, G.C.2
  • 31
    • 68949111886 scopus 로고    scopus 로고
    • SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells
    • Xiao J, Yin S, Li Y, et al (2009). SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells. Acta Biochim Biophys Sin, 41, 699-708.
    • (2009) Acta Biochim Biophys Sin , vol.41 , pp. 699-708
    • Xiao, J.1    Yin, S.2    Li, Y.3
  • 32
    • 36749094533 scopus 로고    scopus 로고
    • Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs
    • Yang M, Mattes J (2008). Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther, 117, 94-104.
    • (2008) Pharmacol Ther , vol.117 , pp. 94-104
    • Yang, M.1    Mattes, J.2
  • 33
    • 77951442337 scopus 로고    scopus 로고
    • Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
    • Yecies D, Carlson NE, Deng J, Letai A (2010). Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood, 115, 3304-13.
    • (2010) Blood , vol.115 , pp. 3304-3313
    • Yecies, D.1    Carlson, N.E.2    Deng, J.3    Letai, A.4
  • 34
    • 84862638645 scopus 로고    scopus 로고
    • Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1
    • Zhang S, Li G, Ma X, et al (2012). Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1. Cell Signal, 24, 1803-9.
    • (2012) Cell Signal , vol.24 , pp. 1803-1809
    • Zhang, S.1    Li, G.2    Ma, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.